PEDIATRICS Vol. 39 No. 2 February 1967, pp. 294-296
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SEARCY, R. L.
Right arrow Articles by ACKERMAN, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SEARCY, R. L.
Right arrow Articles by ACKERMAN, B. D.

Serum Amylase Activity in the Newborn

RONALD L. SEARCY PH.D.1, J. EDWARD BERK M.D.2, SHINICHIRO HAYASHI M.D.2, and BRUCE D. ACKERMAN M.D.3

1 Research Division, Hoffmann-LaRoche, Inc., Nutley, New Jersey 07110
2 Department of Medicine, University of California, California College of Medicine and Los Angeles County General Hospital, Unit 2, Los Angeles, California
3 Department of Pediatrics, University of California, California College of Medicine and Los Angeles County General Hospital, Unit 2, Los Angeles, California

The presence of measurable quantities of amylase in the serum of newborn infants or in serum derived from cord blood may be demonstrated through the use of a sensitive saccharogenic procedure that permits analysis of small quantities of serum. Serum amylase levels are highly variable during the early part of the neonatal period, but they usually tend to be close to or below the lower limits of normal established for adults. The origins of the serum amylase in the newborn infant remain to be elucidated.